Why Is Calidi Biotherapeutics (CLDI) Stock Down 36% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Calidi Biotherapeutics (CLDI) stock is taking a beating on Wednesday following the clinical-stage biotechnology company's public debut. The post Why Is Calidi Biotherapeutics (CLDI) Stock Down 36% Today? appeared first on…#cldi #mintnewmillionaires

Source: Reuters: Health - September 13, 2023 Category: Consumer Health News Source Type: news